ProShare Advisors’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$45K Sell
20,432
-1,234
-6% -$2.72K ﹤0.01% 2003
2025
Q1
$25.1K Sell
21,666
-5,586
-20% -$6.48K ﹤0.01% 2021
2024
Q4
$34.6K Buy
27,252
+6,718
+33% +$8.53K ﹤0.01% 2227
2024
Q3
$70K Buy
20,534
+4,439
+28% +$15.1K ﹤0.01% 1935
2024
Q2
$75.2K Sell
16,095
-4,420
-22% -$20.6K ﹤0.01% 1698
2024
Q1
$152K Buy
20,515
+1,681
+9% +$12.5K ﹤0.01% 1740
2023
Q4
$191K Buy
18,834
+2,811
+18% +$28.5K ﹤0.01% 1650
2023
Q3
$125K Buy
16,023
+2,504
+19% +$19.5K ﹤0.01% 1591
2023
Q2
$111K Buy
13,519
+606
+5% +$4.99K ﹤0.01% 1681
2023
Q1
$93.6K Sell
12,913
-1,664
-11% -$12.1K ﹤0.01% 1602
2022
Q4
$129K Buy
14,577
+1,180
+9% +$10.5K ﹤0.01% 1597
2022
Q3
$164K Buy
13,397
+291
+2% +$3.56K ﹤0.01% 1451
2022
Q2
$154K Sell
13,106
-6,807
-34% -$80K ﹤0.01% 1536
2022
Q1
$379K Sell
19,913
-4,662
-19% -$88.7K ﹤0.01% 1472
2021
Q4
$653K Buy
24,575
+1,228
+5% +$32.6K ﹤0.01% 1284
2021
Q3
$959K Sell
23,347
-6,583
-22% -$270K ﹤0.01% 925
2021
Q2
$1.7M Buy
29,930
+2,780
+10% +$157K 0.01% 779
2021
Q1
$1.14M Buy
27,150
+3,613
+15% +$152K ﹤0.01% 912
2020
Q4
$1.65M Buy
23,537
+5,804
+33% +$407K 0.01% 695
2020
Q3
$498K Buy
17,733
+1,407
+9% +$39.5K ﹤0.01% 949
2020
Q2
$483K Buy
16,326
+6,240
+62% +$185K ﹤0.01% 962
2020
Q1
$200K Sell
10,086
-8,019
-44% -$159K ﹤0.01% 1013
2019
Q4
$536K Sell
18,105
-952
-5% -$28.2K ﹤0.01% 1031
2019
Q3
$433K Sell
19,057
-210
-1% -$4.77K ﹤0.01% 1029
2019
Q2
$477K Sell
19,267
-2,000
-9% -$49.5K ﹤0.01% 1036
2019
Q1
$520K Buy
21,267
+224
+1% +$5.48K ﹤0.01% 1006
2018
Q4
$479K Sell
21,043
-3,984
-16% -$90.7K ﹤0.01% 968
2018
Q3
$796K Sell
25,027
-823
-3% -$26.2K 0.01% 917
2018
Q2
$926K Sell
25,850
-555
-2% -$19.9K 0.01% 858
2018
Q1
$875K Sell
26,405
-1,398
-5% -$46.3K 0.01% 876
2017
Q4
$854K Buy
27,803
+2,036
+8% +$62.5K 0.01% 896
2017
Q3
$619K Buy
25,767
+1,556
+6% +$37.4K 0.01% 885
2017
Q2
$406K Buy
24,211
+3,857
+19% +$64.7K ﹤0.01% 1028
2017
Q1
$454K Sell
20,354
-4,966
-20% -$111K ﹤0.01% 1035
2016
Q4
$411K Buy
+25,320
New +$411K ﹤0.01% 1180